A Practical Guide to Pan Coating and Scale-Up - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

 Pharmaceutical Technology All results
A Practical Guide to Pan Coating and Scale-Up
An understanding of the pan-coating process based on first principles can support successful scale up.
 Jun 20, 2012 Equipment and Processing Report

There are various theories about how to scale up a solid dosage coating operation in a pan coater. This article provides a basic process understanding and scale-up theory based on first principles.

The coating process shown in Figure 1 has multiple, simultaneous, ongoing exchange processes. The first is a heat exchange between the inlet process air and the coater metal body, spray droplets, and tablets. The second is a mass exchange between the material sprayed and the inlet air stream, tablets, and coating pan.

There are certain losses (e.g., heat loss to the metal body and the environment), however, that cannot be characterized easily. An approximate mass and energy balance for the coating process in an equilibrium state can be calculated as shown in Equations 1–3, where H = enthalpy and m = mass.

The heat balance is shown in Equation 1:

The mass balance for the solvent is shown in Equation 2:

The mass balance for the solids sprayed is shown in Equation 3:

As with any theoretical analysis, there are assumptions built into the model described above. For example:

•Leftover material in lines are not considered.
•Heat loss to equipment body and environment are not considered.
•Any unrecoverable mass loss in the process is not accounted for.

This model can be used to calculate process efficiency and efficiency of the inlet air heat capacity. Efficiency of coating will generally improve as the process is scaled up because the bed depth will be increased, thus increasing the heat exchange between the process air and the tablets.

| Weekly
| Monthly
|Monthly
| Weekly
 Survey
What do you think the role of continuous (rather than batch) processes in pharmaceutical manufacturing will be over the next five years?
Many companies in the industry will be using continuous processes for some products.
Companies in both pharmaceutical and biopharmaceutical production will be evaluating continuous processes but few will implement.
Only a few companies will be evaluating or implementing; most will stay with batch processing.
Many companies in the industry will be using continuous processes for some products. 34%
Companies in both pharmaceutical and biopharmaceutical production will be evaluating continuous processes but few will implement. 29%
Only a few companies will be evaluating or implementing; most will stay with batch processing. 38%
Most Viewed Articles
 Columnists Outsourcing Outlook Eric LangerNovel Expression Systems Opening CMO Opportunities sponsored by Ingredients Insider Cynthia Challener, PhDSecuring the Global API Supply Chain Regulatory Watch Jill Wechsler FDA Focuses on Drug Appearance and Attributes European Regulatory WatcchSean MilmoEMA Collaborates with HTA Assessment Networks
 UPCOMING CONFERENCES Serialization Summit San Diego, CA Feb. 27-28, 2014 Advances in Aseptic Processing San Diego, CA Mar. 10-12, 2014 ClinTech 2014 Cambridge, MA Mar. 11-13 2014 Investigator-Initiated and Sponsored Research (IISR) Philadelphia, PA Mar. 19-20 2014 See All Conferences >>
 VALIDATION RESOURCES FROM IVT NETWORK Process Validation Special Editions 19th Annual Validation Week Compendium Computer and Software Validation Volume II Special Edition Analytical Method Validation Toolkit More from IVT